Information

Related Research Units

Research Background

Dr. Renthal is a pediatric endocrinologist, who specializes in the care of children with osteoporosis and skeletal fragility. She serves as the Medical Director of the Bone Health Program at Boston Children’s Hospital & Director of the DXA Center for Pediatric Bone Density. Dr. Renthal holds an MD and PhD from The University of Texas Southwestern Medical Center. She completed her Pediatric residency training at Children’s Medical Center in Dallas, Texas, further specializing through Pediatric Endocrinology Fellowship at Boston Children's Hospital, where she has served as faculty since 2018.

Education

Internship

Pediatrics UT Southwestern Medical Center
2013 Dallas TX

Residency

Pediatrics UT Southwestern Medical Center
2014 Dallas TX

Fellowship

Pediatric Endocrinology Boston Children's Hospital
2018 Boston MA

Media

Parentcast Podcast

Dr. Nora Renthal is featured: How important is bone health for growing kids?

Publications

  1. Moving Towards an Equitable Future: Rethinking the use of Race in Pediatric Densitometry. J Clin Densitom. 2025 Jan-Mar; 28(1):101536. View Abstract
  2. A Multidisciplinary Approach Improves Sexual Health Care for Youth with Duchenne Muscular Dystrophy. J Pediatr. 2024 Aug; 271:114079. View Abstract
  3. Genome-wide CRISPR screening of chondrocyte maturation newly implicates genes in skeletal growth and height-associated GWAS loci. Cell Genom. 2023 May 10; 3(5):100299. View Abstract
  4. Genes with specificity for expression in the round cell layer of the growth plate are enriched in genomewide association study (GWAS) of human height. J Bone Miner Res. 2021 12; 36(12):2300-2308. View Abstract
  5. Histone phosphorylation by TRPM6's cleaved kinase attenuates adjacent arginine methylation to regulate gene expression. Proc Natl Acad Sci U S A. 2017 08 22; 114(34):E7092-E7100. View Abstract
  6. Vitamin D-Dependent Rickets Type 1 Caused by Mutations in CYP27B1 Affecting Protein Interactions With Adrenodoxin. J Clin Endocrinol Metab. 2016 09; 101(9):3409-18. View Abstract
  7. Molecular Regulation of Parturition: A Myometrial Perspective. Cold Spring Harb Perspect Med. 2015 Sep 03; 5(11). View Abstract
  8. Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition. J Clin Invest. 2015 Jul 01; 125(7):2808-24. View Abstract
  9. A novel glucose-insulin infusion maintains perioperative glycaemic control through multiple transitions of care. J Perioper Pract. 2013 Oct; 23(10):222-7. View Abstract
  10. MicroRNAs--mediators of myometrial contractility during pregnancy and labour. Nat Rev Endocrinol. 2013 Jul; 9(7):391-401. View Abstract
  11. The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor. Mol Endocrinol. 2012 Nov; 26(11):1857-67. View Abstract
  12. MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc Natl Acad Sci U S A. 2012 May 08; 109(19):7529-34. View Abstract
  13. Solitary liver mass in a patient with hepatitis C. Clin Gastroenterol Hepatol. 2012 May; 10(5):e46. View Abstract
  14. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A. 2010 Nov 30; 107(48):20828-33. View Abstract
  15. Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide. Immunogenetics. 2011 Jan; 63(1):57-64. View Abstract
  16. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci. 2007 Jan; 10(1):93-9. View Abstract
  17. Neural substrates for sexual and thermoregulatory behavior in the male leopard gecko, Eublepharis macularius. Brain Res. 2004 Dec 10; 1029(1):77-83. View Abstract

Contact Nora Renthal